Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chiara Tognaccini

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
The New England Journal of Medicine|October 8, 2025
Clearance of Squamous-Cell Carcinoma by Restoring T-Cell Receptor SignalingKhushi Gupta, Chiara Tognaccini, Jashin J Wu
Lancet (London, England)|April 19, 2026
Rocatinlimab atopic dermatitis in two global phase 3 clinical trialsKhushi Gupta, Michael Ghebrial, Chiara Tognaccini, et al.
Advances in Therapy|November 1, 2025
Response to Letter Regarding: "Biologic Treatment Adherence and Persistence in Patients with Palmoplantar Pustulosis: A Real-World, Claims-Based Study"Chiara Tognaccini, Leah E Thomas, Dina Ghanim, et al.
The British Journal of Dermatology|June 9, 2026
Comment on 'Incidence and Mortality of Mucous Membrane Pemphigoid in France'Dina Ghanim, Michael Ghebrial, Zahra Ansari, et al.
Cutis|May 15, 2026
Psoriasis and Obesity: A Clinical Review of the Bidirectional Link and Management ImplicationsLeah E Thomas, Dina Ghanim, Michael Ghebrial, et al.
Clinical and Experimental Dermatology|April 15, 2026
Disparities in Pediatric-Eligible Vitiligo Clinical TrialsDina Ghanim, Chiara Tognaccini, Leah E Thomas, et al.
Molecular Metabolism|October 10, 2025
Adipocyte heparan sulfate determines type 2 diabetes susceptibility in mice via FGF1-Mediated glucose regulationChung-Jui Yu, Ariane R Pessentheiner, Sihao Liu, et al.
JCI Insight|September 26, 2024
The human milk oligosaccharide 3'sialyllactose reduces low-grade inflammation and atherosclerosis development in miceAriane R Pessentheiner, Nathanael J Spann, Chloe A Autran, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
The New England Journal of Medicine|October 8, 2025
Clearance of Squamous-Cell Carcinoma by Restoring T-Cell Receptor SignalingKhushi Gupta, Chiara Tognaccini, Jashin J Wu
Lancet (London, England)|April 19, 2026
Rocatinlimab atopic dermatitis in two global phase 3 clinical trialsKhushi Gupta, Michael Ghebrial, Chiara Tognaccini, et al.
Advances in Therapy|November 1, 2025
Response to Letter Regarding: "Biologic Treatment Adherence and Persistence in Patients with Palmoplantar Pustulosis: A Real-World, Claims-Based Study"Chiara Tognaccini, Leah E Thomas, Dina Ghanim, et al.
The British Journal of Dermatology|June 9, 2026
Comment on 'Incidence and Mortality of Mucous Membrane Pemphigoid in France'Dina Ghanim, Michael Ghebrial, Zahra Ansari, et al.
Cutis|May 15, 2026
Psoriasis and Obesity: A Clinical Review of the Bidirectional Link and Management ImplicationsLeah E Thomas, Dina Ghanim, Michael Ghebrial, et al.
Clinical and Experimental Dermatology|April 15, 2026
Disparities in Pediatric-Eligible Vitiligo Clinical TrialsDina Ghanim, Chiara Tognaccini, Leah E Thomas, et al.
Molecular Metabolism|October 10, 2025
Adipocyte heparan sulfate determines type 2 diabetes susceptibility in mice via FGF1-Mediated glucose regulationChung-Jui Yu, Ariane R Pessentheiner, Sihao Liu, et al.
JCI Insight|September 26, 2024
The human milk oligosaccharide 3'sialyllactose reduces low-grade inflammation and atherosclerosis development in miceAriane R Pessentheiner, Nathanael J Spann, Chloe A Autran, et al.
Pageof 1